Establishment and characterization of seven human renal cell carcinoma cell lines

BJU International

Volumn 85, Issue 1, 2000, Pages 130-138

  Shin, K H ^a   Ku, J L ^a   Kim, W H ^b   Lee, S E ^b   Lee, C ^b   Kim, S W ^b   Park, J G ^a,b  

^a Korean Cell Line Bank   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

Cell lines; Microsatellite instability; Mismatch repair genes; Renal cell carcinoma; Tumour suppressor genes

Indexed keywords

ADENINE; GROWTH FACTOR RECEPTOR; PROTEIN P53; TRANSFORMING GROWTH FACTOR BETA2;

ADULT; AGED; ARTICLE; BACTERIUM CONTAMINATION; BASE MISPAIRING; CANCER CELL CULTURE; CANCER TISSUE; CELL GROWTH; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; DEVICE; DNA FINGERPRINTING; DNA REPAIR; FEMALE; FRAMESHIFT MUTATION; GENE MUTATION; GRANULAR CELL; HISTOPATHOLOGY; HOMOZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; KIDNEY CARCINOMA; MALE; MICROSATELLITE INSTABILITY; MISSENSE MUTATION; MOLECULAR BIOLOGY; MYCOPLASMA; NUCLEOTIDE REPEAT; PHENOTYPE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0033974194     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.2000.00247.x     Document Type: Article

References (35)

1. 1 Grossman HB, Wedemeyer G, Ren L. Human renal carcinoma: Characterization of five new cell lines. J Surg Oncol 1985; 28: 237-44
2. 2 Anglard P, Trahan E, Liu S et al. Molecular and cellular characterization of human renal cell carcinoma cell lines. Cancer Res 1992; 52: 348-56
3. 3 Gerharz CD, Ramp U, Olert J et al. Cytomorphological, cytogenetic, and molecular biological characterization of four new human renal carcinoma cell lines of the clear cell type. Virchows Archiv 1994; 424: 403-9
4. 4 Duan DR, Pause A, Burgess WH et al. Inhibition of transcription elongation by the VHL tumor suppressor protein. Science 1995; 269: 1402-6
5. 5 Chen F, Kishida T, Dun F-M et al. Suppression of growth of renal carcinoma cells by the von Hippel-Lindau tumor suppressor gene. Cancer Res 1995; 55: 4804-7
6. 6 Gnarra JR, Tory K, Weng Y et al. Mutations of the VHL tumor suppressor gene in renal carcinoma. Nat Genet 1994; 7: 85-9
7. 7 Herman JG, Latif F, Weng Y et al. Silencing of the VHI, tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci USA 1994; 91: 9700-4
8. 8 Lu S-L, Zhang W-C, Akiyama Y, Nomizu T, Yuasa Y. Genomic structure of the transforming growth factor β type II receptor gene and its mutalion in hereditary nonpolyposis colorectal cancers. Cancer Res 1996; 56: 4595-8
9. 9 Parsons R, Myeroff L, Liu B et al. Microsatellite instability and mutations of the transforming growth factor β type II receptor gene in coloreclal cancer. Cancer Res 1995; 55: 5548-50
10. 10 Myeroff LL, Parsons R, Kim S-J et al. A transforming growth factor β receptor type II gene mutation common in colon and gastric by rare in endometrial cancers with microsatellite instability. Cancer Res 1995; 55: 5545-7
11. 11 Wang J. Sun L, Myeroff L et al. Demonstration that mutation of the type II transforming growth factor β receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells. J Biol Chem 1995; 37: 22044-9
12. 12 Liu B, Nicolaides NT, Markowitz S et al. Mismatch repair gene defects in sporadic coloredal cancers wilh microsatellite instability. Nat Genet 1995; 9: 48-55
13. 13 Loeb LA. Microsatellite instability: marker of a mutator phenotype in cancer. Cancer Res 1994; 54; 5059-63
14. 14 Hoang J-M, Cottu PH, Thuille B, Salmom RJ, Thomas G, Hamelin R. BAT-26, an indicator of the replication error phenotype in colorectal cancers and cell lines. Cancer Res 1997; 57: 300-3
15. 15 Rampino N, Yamamoto H, Ionov Y et al. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science 1997; 275: 967-9
16. 16 Ouyang H, Shiwaku HO, Hagiwara H et al. The insulin-like growth factor II receptor gene is mutated in genetically unstable cancers of the endometrium, stomach, and colorectum. Cancer Res 1997; 57: 1851-4
17. 17 Risinger JI, Umar A, Boyd J, Berchuck A, Kunkel TA, Barrett JC. Mutalion of MSH3 in endometrial cancer and evidence for its functional role in heteroduplex repair. Nat Genet 1996; 14: 102-5
18. 18 Park J-G. Lee J-H, Kang M-S et al. Characteristics of cell lines established human hepatocellular carcinoma, Int J Cancer 1995; 62: 276-82
19. 19 Ku J-L, Kim W-H, Park H-S, Kang S-B, Park J-G. Establishment and characterization of 12 uterine cervicalcarcinoma cell lines. Common sequence variation in the E7 gene of HPV-16-positive cell lines. Int J Cancer 1997; 72: 313-20
20. 20 Goding JM. Detection of mycoplasma contamination. In Monoclonal Antibody: Principles and Practice, 3rd edn, San Diego, Academic Press, 1996: 181-3
21. 21 Lee JY, Dong SM, Kim HS et al. A distinct region of chromosome 19p13.3 associated with the sporadic form of adenoma malignum of the uterine cervix. Cancer Res 1998; 58: 1140-3
22. 22 Shuin T, Kondo K, Torigoe S et al. Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas. Cancer Res 1994; 54: 2852-5
23. 23 Han H-J, Maruyama M, Baba S, Park J-G, Nakamura Y. Genomic structure of human mismatch repair gene, hMLH1, and its mutation analysis in patients with hereditary nonpolyposis colorectal cancer (HNPCC). Hum Mol Genet 1995; 4: 237-42
24. 24 Liu B, Parson RE, Hamilton SR et al. hMSH2 mutations in hereditary nonpolyposis colorectal cancer kindred. Cancer Res 1994; 54: 4590-4
25. 25 Kang MS, Lee HJ, Lee JH el al. Mutation of p53 gene in hepatocellular carcinoma cell lines with HBX DNA. Int J Cancer 1996; 67: 1-5
26. 26 Shin K-H, Min B-M, Cherrick HM, Park N-H. Combined effects of human papillomavirus-18 and N-methyl-N'-nitro-N-nitrosoguanidine on the transformation of normal oral keratinocytes. Molecular Carcinogenesis 1994; 9: 76-86
27. 27 Nigro SJ. Baker SJ, Preisinger AC et al. Mutations in the p53 gene occur in diverse human tumor types. Nature 1989; 342: 705-8
28. 28 Giard DJ, Aaronson SA, Todaro GJ et al. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst 1973; 51: 1417-23
29. 29 Ebert T, Bander NH, Finstad CL, Ramsawak RD, Old LJ. Establishment and characterization of human renal cancer and normal kidney cell lines. Cancer Res 1990; 50: 5531-6
30. 30 Susuki Y, Tamura G, Satodale R, Fujioka T. Infrequent mutation of p53 gene in human renal cell carcinoma detected by polymorphism. Jap J Cancer 1992; 83: 233-5
31. 31 Uchida T, Wada C, Shitara T, Egawa S, Mashimo S, Koshiba K. Infrequent involvement of p53 mutation and loss of helerozygosity of 17q in the tumorigenesis of renal cell carcinoma. J Urol 1993; 150: 1298-301
32. 32 Kamel D, Turpeenniemi-Hujanen T, Vahakangas K, Paakko P, Soini Y. Proliferating cell nuclear antigen but not p53 or human papillomavirus DNA correlates with advanced clinical stage in renal cell carcinoma. Histopathology 1994; 25: 339-47
33. 33 Schmidt L, Duh FM, Kishida T et al. Germline and somatic mutations in the tyrosine kinase domain of the MET protooncogene in papillary renal carcinoma. Nat Genet 1997; 16: 68-73
34. 34 Duh FM, Scherer SW. Tsui LC, Lerman MI, Schmidt L. Gene structure of the human MET proto-oncogene. Onrogene 1997; 15: 1583-6
35. 35 Uchida T, Wada C, Wang C, Egawa S, Ohtani H, Koshiba K. Genomic instability of microsatellite repeats and mutations of H-, K-, and N-ras and p53 genes in renal cell carcinoma. Cancer Res 1994; 54: 3682-5